Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Aprotinin Inhibits SARS-CoV-2 Replication.
Bojkova D, Bechtel M, McLaughlin KM, McGreig JE, Klann K, Bellinghausen C, Rohde G, Jonigk D, Braubach P, Ciesek S, Münch C, Wass MN, Michaelis M, Cinatl J Jr. Bojkova D, et al. Among authors: bechtel m. Cells. 2020 Oct 30;9(11):2377. doi: 10.3390/cells9112377. Cells. 2020. PMID: 33143316 Free PMC article.
COVID-19-Related Coagulopathy-Is Transferrin a Missing Link?
McLaughlin KM, Bechtel M, Bojkova D, Münch C, Ciesek S, Wass MN, Michaelis M, Cinatl J Jr. McLaughlin KM, et al. Among authors: bechtel m. Diagnostics (Basel). 2020 Jul 30;10(8):539. doi: 10.3390/diagnostics10080539. Diagnostics (Basel). 2020. PMID: 32751741 Free PMC article.
Enisamium Inhibits SARS-CoV-2 RNA Synthesis.
Elli S, Bojkova D, Bechtel M, Vial T, Boltz D, Muzzio M, Peng X, Sala F, Cosentino C, Goy A, Guerrini M, Müller L, Cinatl J, Margitich V, Te Velthuis AJW. Elli S, et al. Among authors: bechtel m. Biomedicines. 2021 Sep 17;9(9):1254. doi: 10.3390/biomedicines9091254. Biomedicines. 2021. PMID: 34572438 Free PMC article.
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial.
Holubovska O, Bojkova D, Elli S, Bechtel M, Boltz D, Muzzio M, Peng X, Sala F, Cosentino C, Mironenko A, Milde J, Lebed Y, Stammer H, Goy A, Guerrini M, Mueller L, Cinatl J, Margitich V, Te Velthuis AJW. Holubovska O, et al. Among authors: bechtel m. medRxiv. 2021 Jan 21:2021.01.05.21249237. doi: 10.1101/2021.01.05.21249237. Preprint. medRxiv. 2021. PMID: 33469600 Free PMC article.
Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy.
Bojkova D, Costa R, Reus P, Bechtel M, Jaboreck MC, Olmer R, Martin U, Ciesek S, Michaelis M, Cinatl J Jr. Bojkova D, et al. Among authors: bechtel m. Metabolites. 2021 Oct 13;11(10):699. doi: 10.3390/metabo11100699. Metabolites. 2021. PMID: 34677415 Free PMC article.
Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells.
Schäfer R, Spohn G, Bechtel M, Bojkova D, Baer PC, Kuçi S, Seifried E, Ciesek S, Cinatl J. Schäfer R, et al. Among authors: bechtel m. Stem Cell Reports. 2021 Mar 9;16(3):419-427. doi: 10.1016/j.stemcr.2020.09.003. Epub 2020 Sep 11. Stem Cell Reports. 2021. PMID: 32950067 Free PMC article.
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis.
McLaughlin KM, Bojkova D, Kandler JD, Bechtel M, Reus P, Le T, Rothweiler F, Wagner JUG, Weigert A, Ciesek S, Wass MN, Michaelis M, Cinatl J Jr. McLaughlin KM, et al. Among authors: bechtel m. Curr Issues Mol Biol. 2021 Sep 22;43(3):1212-1225. doi: 10.3390/cimb43030086. Curr Issues Mol Biol. 2021. PMID: 34698067 Free article.